Basic info
Industry
biotechnology research
Sectors
Biotechnology
Basal Cell Carcinoma
pharmaceuticals
Gorlin Syndrome
Therapeutics
Biotech
Dermatological Diseases
Medical Device
dermatology
Hedgehog Signaling
rare disease
Date founded
2016
Funding rounds raised
Total raised
$20M
from 1 investors over 1 rounds
P
PellePharm raised $20M on August 1, 2017
Investors: BridgeBio